MUSHTAQ A SYED
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism INDIANA, PA NPI 1649230855
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism PA Amgen Inc. All categories
General Payments — all program years on this page
$113,358.50
- Category: General Payments
- Program years: PY2018–2024
- Record count: 754
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,829.57 across 67 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,536.07 | 65 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,251.00 | 1 |
| Gift | $42.50 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $1,389.38 | 7 |
| Lilly USA, LLC | $204.30 | 12 |
| Abbott Laboratories | $179.59 | 4 |
| Medtronic, Inc. | $166.28 | 6 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $130.89 | 8 |
| Ascendis Pharma Inc | $129.18 | 1 |
| MannKind Corporation | $119.16 | 5 |
| CeQur Corporation | $96.96 | 1 |
| Xeris Pharmaceuticals, Inc. | $63.17 | 3 |
| Averitas Pharma Inc. | $47.47 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $46.48 | 3 |
| BETA BIONICS, INC. | $37.03 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $35.64 | 2 |
| Corcept Therapeutics | $31.74 | 2 |
| Acerta Pharma LLC | $30.69 | 2 |
| DEXCOM, INC. | $30.38 | 1 |
| Alexion Pharmaceuticals, Inc. | $21.94 | 1 |
| Novo Nordisk AS | $21.77 | 1 |
| SANOFI-AVENTIS U.S. LLC | $18.07 | 1 |
| ABBVIE INC. | $15.84 | 1 |
| Radius Health, Inc. | $13.61 | 1 |
By program year
Records — PY2024 (67)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.